News about

J&J, Up 26% YTD, Gets After Image Problems

Tue, 21 May 2013 15:32:48 -0400

Investment That Protects You From Yourself: Bonds

Tue, 21 May 2013 09:55:48 -0400

Is There a Pill For That? Forest Labs’ Iffy Pipeline

Tue, 21 May 2013 09:27:09 -0400

6 Healthy Products That Aren't

Mon, 20 May 2013 15:30:00 -0400

False claims about amazing healthful benefits are still a surefire way for companies to move merchandise. Don't fall for these "breakthrough" products.

J&J, Up 25% YTD, Shrugs Off Risperdal Suits

Fri, 17 May 2013 14:13:59 -0400

Small Is Beautiful: Now's the Time for Growth-Oriented Investors to Move Into Small-Cap Stocks

Fri, 17 May 2013 11:22:00 -0400

Portfolios focusing on low-volatility, high-quality small-cap stocks may be able to reduce overall portfolio volatility and achieve better returns.

Defensive stocks due for a pullback

Fri, 17 May 2013 07:00:51 -0400

This year has seen the stunning performance of defensive stocks, those steady, low-beta stocks that tend to zig when the economy zags, writes Howard Gold. But have these shares reached a top?

(SNY) Sanofi Earnings Plummet – Outlook Maintained

Thu, 16 May 2013 16:22:21 -0400

Sanofi (SNY) reported first quarter 2013 business earnings of 81 cents per American Depository...

Visit StockBlogHub to view complete post.

X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 23

Thu, 16 May 2013 10:38:00 -0400

Johnson & Johnson, Assurant, and Dunkin' Brands are on the list.

(LIFE) MedTech Industry Stock Update – May 2013 – Zacks Analyst Interviews

Wed, 15 May 2013 18:34:08 -0400

As expected, MedTech mergers and acquisitions (M&A) are heating up in 2013. Finally, the...

Visit StockBlogHub to view complete post.

Health Care Is Hot, but Technology Offers Better Value

Tue, 14 May 2013 13:40:00 -0400

Consider shifting your portfolio from more defensive stocks to growth sectors.

Stock Market News for May 14, 2013 – Market News

Tue, 14 May 2013 10:36:01 -0400

Major indices finished mixed following better-than-expected retail sales data and discouraging economic reports from China

How to Find: Low-Volatility Stocks, Not Overpriced

Tue, 14 May 2013 09:47:15 -0400

Stock Market News for May 13, 2013 – Market News

Mon, 13 May 2013 10:36:01 -0400

Benchmarks finished in the green riding on positive investor sentiment

Stock Buybacks: We Separate Smart from Dumb

Mon, 13 May 2013 08:23:29 -0400

We’re eating more sugar, less Splenda

Mon, 13 May 2013 08:11:36 -0400

Sales of white sugar are up, as the big artificial sweeteners struggle.

A new lineup for the American Heroes portfolio

Sun, 12 May 2013 10:37:02 -0400

Here's how we refreshed the model.

A new lineup for the American Heroes portfolio

Sun, 12 May 2013 10:37:02 -0400

Here's how we refreshed the model.

Short Interest in Vertex Rises, in Celgene Falls

Sat, 11 May 2013 10:45:31 -0400

The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April.

The number of shares sold short in Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN), Onyx Pharmaceuticals (NASDAQ: ONXX) and VIVUS (NASDAQ:

J&J: Before We Hand Over That $2.2 Billion . . .

Fri, 10 May 2013 13:48:14 -0400

Stock shorts get hurt, but don’t call it a squeeze

Fri, 10 May 2013 11:28:29 -0400

It has been an undeniably ugly week for short sellers, but don’t pin too much credit for the broad equity rally on a squeeze.

S&P Highlights Biotech ETFs

Fri, 10 May 2013 07:39:21 -0400

Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks and ETFs have been stellar performers in 2013.

Recently, it was an announcement by Vertex (NASDAQ: VRTX) that its cystic fibrosis

Six Superstars for Your Biotech Portfolio: John McCamant

Thu, 09 May 2013 18:15:36 -0400

Six Superstars for Your Biotech Portfolio: John McCamant Source: Tracy Salcedo-Chourr? of The Life Sciences Report (5/9/13) http://www.thelifesciencesreport.com/pub/na/15256 We are in the “golden age,” of biotech, and Medical Technology Stock Letter Editor John McCamant has innovative ideas on how to glean profits from the renaissance. Investors should be looking at companies with excellent management and platform technologies that offer [...]

Earnings Miss at SurModics – Analyst Blog

Wed, 08 May 2013 18:39:01 -0400

SRDX earnings (excluding special items) of 20 cents per share missed the Zacks Consensus Estimate by 2 cents.

Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio

Wed, 08 May 2013 04:51:16 -0400

Below are the top drug manufacturers-major stocks on the NYSE in terms of PEG ratio.

WuXi PharmaTech (Cayman) (NYSE: WX) has a PEG ratio of 1.12. WuXi PharmaTech's trailing-twelve-month revenue is $499.91 million.

Abbott Laboratories (NYSE: ABT) has a PEG ratio of 1.50. Abbott's trailing-twelve-month operating margin is

Florida Won't Protect Biotechs From Competition

Tue, 07 May 2013 13:13:46 -0400

Three Top Performing Healthcare Stocks to Watch

Mon, 06 May 2013 15:53:30 -0400

The healthcare sector has been a very strong performer in 2013, driven in part by a near 12 percent rise in the S&P 500.

The iShares Dow Jones US Healthcare ETF (NYSE: IYH) had climbed better than 19 percent and the SPDR S&P Biotech ETF (NYSE: XBI)

J&J recalls Children’s Tylenol in South Korea

Fri, 03 May 2013 15:48:09 -0400

Johnson & Johnson recalls all bottles of Children’s Tylenol that it made and sold in South Korea because of high levels of the main ingredient.

Record Highs from the Kamikaze Rally

Fri, 03 May 2013 15:05:24 -0400

Stocks rally for plenty of reasons. Right now, one of the main ones is probably quantitative easing.

Buzz on the Street: The S&P 500 Smashes Through 1600

Fri, 03 May 2013 15:00:00 -0400

A look back at the happenings on Wall Street this week, as seen by Minyanville's Buzz & Banter.

Earnings Plummet, Outlook Maintained at Sanofi – Analyst Blog

Fri, 03 May 2013 13:30:01 -0400

Sanofi reported first quarter 2013 business earnings of 81 cents per American Depository Share

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential

Thu, 02 May 2013 18:22:46 -0400

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to catalysts in the drug development process that typically move biotechnology stocks. All stocks are affected by catalysts, [...]

(JNJ) Protect Yourself From Gold

Thu, 02 May 2013 17:12:30 -0400

Gold is supposed to act as a safe haven from crisis and a hedge against inflation. But lately, it...

Visit StockBlogHub to view complete post.

Wider-Than-Expected Loss at Pharmacyclics – Analyst Blog

Thu, 02 May 2013 15:00:01 -0400

Pharmacyclics' first quarter 2013 loss was wider than the year-ago loss.

The Stock Buffett Ought to Be Bragging About

Thu, 02 May 2013 10:06:33 -0400

Earnings Trigger Volume Spike in Pharma ETF

Wed, 01 May 2013 14:41:27 -0400

On Tuesday, it was Pfizer (NYSE: PFE).

Wednesday, it is Merck (NYSE: MRK). Earnings reports from the two pharmaceuticals giants and Dow components have triggered two consecutive volume spikes in the Market Vectors Pharmaceuticals ETF (NYSE: PPH), an arguably under-appreciated play on one this

Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration

Wed, 01 May 2013 12:08:57 -0400

Janssen Research & Development, LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for daratumumab for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who

Investing in sinners and saints

Wed, 01 May 2013 06:01:08 -0400

Is socially responsible or so-called white hat investing better for your conscience than your wallet?

(JNJ) BioLineRx to Start BL-8040 Study

Sat, 27 Apr 2013 19:05:50 -0400

BioLineRx (BLRX) recently received approval in the US for the initiation of a multi-center,...

Visit StockBlogHub to view complete post.

Short Sellers Move into Celgene, Regeneron

Fri, 26 Apr 2013 13:25:43 -0400

The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April.

The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Amgen (NASDAQ: AMGN), Biogen Idec (NASDAQ: BIIB), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ:

Where Is the Larger Bubble, in Stocks or Bonds?

Fri, 26 Apr 2013 10:50:00 -0400

When these bubbles finally pop, the result is going to devastate financial markets.

Dividend Payout Changes for Apr.25

Thu, 25 Apr 2013 17:15:05 -0400

The following companies announced a change in their dividend payouts today. Companies Increasing Dividend Payouts Atlas Pipeline Partners LP (APL) has raised its annual dividend payout from $2.32 to $2.36. The new dividend yield, based on today’s closing stock price of $36.18, is 6.52%. APL is not a “Recommended” stock at this time, holding a [...]

Yes, This ETF Offers Dividend Growth

Thu, 25 Apr 2013 14:00:35 -0400

Professionals and pundits can argue until the cows come home about why conservative, low volatility sectors such as consumer staples and health care have been leading the market higher for about three years now. An obvious reason is that these sectors and some others are chock full of stocks

Elan Narrows Y/Y Loss – Analyst Blog

Thu, 25 Apr 2013 13:09:01 -0400

Elan reported a loss of 12 cents per share from its continuing operations in the first quarter of 2013

Johnson & Johnson Announces Dividend Increase of 8.2% to $0.66 per Share

Thu, 25 Apr 2013 10:38:14 -0400

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared an 8.2% increase in the quarterly dividend rate, from $0.61 per share to $0.66 per share. The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, NJ.

"In recognition

Stocks Market News for April 25, 2013 – Market News

Thu, 25 Apr 2013 10:36:01 -0400

A sharp fall in durable orders coupled with disappointing data from Procter & Gamble and AT&T dragged the Dow Jones into negative territory on Wednesday

Gilead Reports Encouraging HCV Data – Analyst Blog

Wed, 24 Apr 2013 19:40:01 -0400

Gilead announced detailed data on sofosbuvir

Abbott – Epizyme Collaborate – Analyst Blog

Tue, 23 Apr 2013 19:00:01 -0400

Abbott Labs announced a strategic deal with Epizyme, Inc. for the development of a molecular companion diagnostic test for use with EPZ-5676

(JNJ) Will Johnson & Johnson Miss on Earnings?

Tue, 23 Apr 2013 14:08:31 -0400

Johnson & Johnson (JNJ) is scheduled to report its first quarter 2013 results on Apr 16, 2013...

Visit StockBlogHub to view complete post.

Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation

Tue, 23 Apr 2013 12:55:00 -0400

ARN-509 will absolutely be competitive with Medivation's Xtandi... in another decade.